|
Forward-looking intelligence allows you time to act. View this video on our restructuring content to see how you can benefit from our expertise.
| ||
NOT A SUBSCRIBER?Genentech shares dropPosted on February 27, 2009 9:30 AM
The Obama administration is giving Roche Holdings AG a little help in its attempt to buy in biotechnology company Genentech Inc., but probably not enough to get Genentech minority shareholders to accept its current offer. In recent days, following Genentech's Securities and Exchange Commission filings in response to Roche's $86.50 per share tender offer for the 44.2% of Genentech it does not own, Genentech shares have traded over the value of the bid. This is a free preview of the content available in The Deal Pipeline. Subscribers enjoy access to the full story, as well as second-to-none research tools. To request a demo, or, if you are an existing user to The Deal Pipeline, log in to your account, please scroll down and click the button. Dig deeper, with Pipeline.
| ||
Michael Crosby mcrosby@thedeal.com 212.313.9325 |
Martha Brown mbrown@thedeal.com 212.313.9218 |